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The British Hepatic Angiosarcoma
Register
by Peter J. Baxter*
A register of British cases of primary hepatic angiosarcoma (HAS) was established in 1974 to
monitor the occurrence ofcases from 1963 onwards. Details of cases dying in 1963-77 have been
obtained. Thirty-five cases were agreed as HAS by a panel ofliver pathologists, and occupational
and medical information was obtained in the majority of these. Two cases were attributable to
VCM exposure, and eight others had received intra-arterial Thorotrast. In 1978-79, two more
cases were confirmed in VCM polymerization workers.
Introduction
In 1974, the Health and Safety Executive em-
barked upon a mortality study of all workers in
Great Britain who had been exposed to vinyl
chloride in the manufacture ofvinyl chloride (VCM)
or poly(vinyl chloride) (PVC), and a register of
British cases ofprimaryhepaticangiosarcoma (HAS).
The mortality study embraced over 7000 people,
and an analysis ofdeaths up to the end of 1974 has
been published (1). The main finding was four
certified cases of liver cancer, two of which were
histologically confirmed HAS. An update of this
analysis has been postponed while, with the collab-
oration of the factories concerned, exposure data
are being refined to take into account job changes
and exposure to PVC dust. A mortality study of
PVC fabricators was considered, but remains inthe
planning stage. The register is also the basis for a
case-control study of occupation for those cases
occurring from 1974 onwards (2).
To determine the annual occurrence of HAS and
to monitor its incidence, cases dying in 1963-73
were reviewed as well as those occurring after this
period. Information on cases for the 15 years
1963-77 has now been obtained and will be outlined
here. Further details may be found elsewhere (3,
4).
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Methods
Cases were identified by a search of death
certificates in seven appropriate categories of the
International Classification of Diseases for a diag-
nosis of HAS (or one of its synonyms). Hospital
pathologists and cancer registries were requested
to report cases, as were the medical departments of
factories manufacturing VCM or PVC. Some cases
were identified from publications. When available,
histological material was sought for all the reported
cases and submitted to a panel of three liver
pathologists (Drs. P. P. Anthony, R. N. M.
MacSween and P. J. Scheuer), who reviewed the
slides independently and without knowledge ofthe
prior diagnoses. For control purposes, histological
material from otherliver cancers was included. For
those cases agreed by the panel as HAS, the full
medical records were sought and further informa-
tion, forexample, occupational histories and alcohol
consumption, was obtained when possible by inter-
view with the next of kin.
Results and Discussion
Eighty-eight cases were reported from all sources.
The panel agreed the diagnosis in 32 cases and
three more were agreed from among the controls.
In half of the confirmed cases the diagnosis had
been recorded on the death certificate, but the
remainder would have been missed if reliance had
been placed upon death certificates as the sole
method ofascertainment. At least some clinical and
115necropsy details were obtained in all but two pa-
tients. Occupational histories were obtained in
91%, the occupationrecorded onthedeath certificate
being accepted for the remainder.
The annual numbers of both reported cases and
those agreed by the panel increased after 1975, so
that in 1977, 12 cases were reported, 10 of which
were agreed by the panel. Between 1968 and 1977
an average eight cases per annum were reported
and three per annum were agreed by the panel, the
population ofBritain during this period being about
50 million. The observed increase in incidence was
almost entirely due to 10 cases of known etiology;
eight were patients who had received intra-arterial
Thorotrast (a colloidal suspension of thorium diox-
ide), and two others had been VCM polymerization
workers. Plotting on a map the last places of
residence ofall 35 agreed cases revealed acluster of
six Thorotrast cases in or around Edinburgh,
where the use ofThorotrast in neurological diagno-
sis had been greater than at any other British
center. One hundred and nine patients who had
received intra-arterial Thorotrast in Edinburgh
during 1933-48 have been followed up in detail (5):
about three quarters ofthese patients have died, 13
(17%) from liver tumors. Histological material for
review by the panel was available in nine ofthese.
In those cases dying in earlier years, the tumors
were predominantly cholangiocarcinomas, but later
cases were all HAS, confirming that the recent
emergence ofThorotrast-induced HAS in Britain is
a real increase in incidence and not an artifact due
to under-reporting of cases occurring in the past.
Twenty-eight of the 35 cases were males; one
female infant died aged 8 months. For idiopathic
cases, the male:female ratio was 4:1. Adult cases
were assigned to one ofthe Registrar General's five
social classes according to the occupation on the
death certificates. The social class distribution was
unremarkable, except that the only cases in social
classes one and two were four men, all of whom
were designated as electrical engineers. In fact, six
out of the 28 males had worked in the electrical
industry at some time, a figure in excess of any
other industry. Three other men had been em-
ployed in workplaces where PVC was fabricated,
but the occupational histories were inadequate to
confirm that these men had worked with PVC. One
other male case had lived for six years before his
death within a half mile of a plant manufacturing
PVC. Occupational exposure to arsenic did not
appear to be a factor in any of these cases.
Arsenical drugs were commonly prescribed in Brit-
ain in the past and, in a few areas, even until the
early 1960's. However, one case only was suspected
to have clinical evidence ofchronic arsenical intoxi-
cation, but nail and hair analyses for arsenic were
negative and the medical records were inadequate
for verifying the use of arsenical drugs. None of
these cases was recorded to have taken androgenic
steroids (6), but one woman had taken an estrogen
preparation for several years. Alcohol did not
appear to be an important factor in the majority of
cases, only four men having a history of heavy
consumption.
In its age distribution, clinical presentation and
prognosis, HAS resembled primary liver carcinoma
(4). 'Upper abdominal pain and a hepatic mass
were the commonest presentation, and extrahepatic
metastases were found in 23% of cases only. Ex-
cluding the Thorotrast cases, and for men only, the
median interval between the onset of symptoms
and death was six months for those aged under
sixty years, and only six weeks forthose aged sixty
and over, a difference which was statistically highly
significant. Hemochromatosis was not evident in
any of the cases.
In 1978-79, two more cases of HAS have been
confirmed in polymerization workers, and another
case has led to speculation that hydrazine deriva-
tives, such as phenelzine, may induce angiosarcoma
in man (7). It is too early to predict the full impact
of past industrial exposure to VCM in Britain and
at least until the picture becomes clearer the
monitoring of HAS should continue.
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